Galera Therapeutics

Galera Therapeutics

Galera Therapeutics

Galera Therapeutics develops therapeutic agents for preventing damage to normaltissues during the radiation treatment of cancer.
Founded
2009
Raised
$68M
Follow us
Latest funding Show all
$15,000,000
Venture capital (Series B) - 2016
Sofinnova Ventures
$5,000,000
Venture capital (Series B) - 2016
Enso Ventures
Team Size
10+
Employees
PE Hub

Galera Therapeutics fetches $150 mln Series C

$15,000,000 Venture capital (Series B)
FinSMEs

Galera Therapeutics Receives $15M from Sofinnova Ventures

Funding Health Science
$5,000,000 Venture capital (Series B)
FinSMEs

Galera Therapeutics Raises $5M; Closes 42M Series B Round

Health Funding Science